Author

Nagendra Sastry Yarla

Duke University - Cited by 2,852 - Drug discovery and development - cancer vaccine development - inflammation and immunotherapy - tumor immunology - inflammatory disea

Biography

Dr. Sastry has completed his Secondary School Education from Board of Secondary Education, Andhra Pradesh in 2003 with 80 percentage and studied his Higher Secondary Education from Board of Intermediate Education, Andhra Pradesh in 2005 with 60 percentage and got into his BSc in Biotechnology, Biochemistry and Microbiology from Andhra University in 2008 with 68 percentage and achieved his masters M.Sc Biochemistry from GITAM University, Visakhapatnam in 2011 with 8.68 CGPA and currently doing his phd in Gitam university,Visakhapatnam, India.
Title
Cited by
Year
Phytol: A review of biomedical activities
MT Islam, ES Ali, SJ Uddin, S Shaw, MA Islam, MI Ahmed, MC Shill, ...Food and chemical toxicology 121, 82-94, 2018201
242
2018
MAPK signalling pathway in cancers: Olive products as cancer preventive and therapeutic agents
I Peluso, NS Yarla, R Ambra, G Pastore, G PerrySeminars in cancer biology 56, 185-195, 2019201
115
2019
Clinically relevant anti-inflammatory agents for chemoprevention of colorectal cancer: new perspectives
A Mohammed, NS Yarla, V Madka, CV RaoInternational journal of molecular sciences 19 (8), 2332, 2018201
59
2018
Preventive and therapeutic potentials of anthocyanins in diabetes and associated complications
S Putta, NS Yarla, E Kumar K, DB Lakkappa, MA Kamal, L Scotti, ...Current medicinal chemistry 25 (39), 5347-5371, 2018201
43
2018
Current insights into functions of phospholipase A2 receptor in normal and cancer cells: More questions than answers
O Sukocheva, M Menschikowski, A Hagelgans, NS Yarla, G Siegert, ...Seminars in cancer biology 56, 116-127, 2019201
32
2019
Regulatory role of sphingosine kinase and sphingosine-1-phosphate receptor signaling in progenitor/stem cells
ML Ng, NS Yarla, M Menschikowski, OA SukochevaWorld Journal of Stem Cells 10 (9), 119, 2018201
30
2018
Mitochondrial dynamics and proteins related to neurodegenerative diseases
A Alexiou, B Nizami, FI Khan, G Soursou, C Vairaktarakis, S Chatzichronis, ...Current Protein and Peptide Science 19 (9), 850-857, 2018201
30
2018
Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention
NS Yarla, H Gali, G Pathuri, S Smriti, M Farooqui, J Panneerselvam, ...Seminars in cancer biology 56, 168-174, 2019201
26
2019
Implications of farnesyltransferase and its inhibitors as a promising strategy for cancer therapy
SG Klochkov, ME Neganova, NS Yarla, M Parvathaneni, B Sharma, ...Seminars in cancer biology 56, 128-134, 2019201
25
2019
Role of GTPases in the regulation of mitochondrial dynamics in Alzheimer’s disease and CNS-related disorders
A Alexiou, G Soursou, S Chatzichronis, E Gasparatos, MA Kamal, ...Molecular neurobiology 56, 4530-4538, 2019201
24
2019
Salidroside-can it be a multifunctional drug?
SKJ Magani, SD Mupparthi, BP Gollapalli, D Shukla, AK Tiwari, ...Current Drug Metabolism 21 (7), 512-524, 2020202
23
2020
Small molecule tyrosine kinase inhibitors and pancreatic cancer—Trials and troubles
BVKS Lakkakula, B Farran, S Lakkakula, S Peela, NS Yarla, ...Seminars in cancer biology 56, 149-167, 2019201
23
2019
Epigenetic mechanisms: role in hematopoietic stem cell lineage commitment and differentiation
S Raghuwanshi, S Dahariya, R Kandi, U Gutti, RB Undi, DS Sharma, ...Current Drug Targets 19 (14), 1683-1695, 2018201
17
2018
Late-life depression and Alzheimer disease: a potential synergy of the underlying mechanisms
J Leszek, E Trypka, E Koutsouraki, D Michmizos, NS Yarla, VV Tarasov, ...Current Medicinal Chemistry 25 (39), 5389-5394, 2018201
16
2018
Single probiotic versus multiple probiotics-a debate on current scenario for alleviating health benefits
SK Korada, NS Yarla, V Mishra, MA Daim, B Sharma, A Gm, I Peluso, ...Current Pharmaceutical Design 24 (35), 40-43, 2018201
15
2018
Applications of multi-target computer-aided methodologies in molecular design of CNS drugs
OA Raevsky, A Mukhametov, VY Grigorev, A Ustyugov, SC Tsay, ...Current Medicinal Chemistry 25 (39), 5293-53, 2018201
14
2018
Molecular targets in precision chemoprevention of colorectal cancer: an update from pre-clinical to clinical trials
NS Yarla, V Madka, G Pathuri, CV RaoInternational Journal of Molecular Sciences 21 (24), 9609, 2020202
14
2020
Features, pharmacological chemistry, molecular mechanism and health benefits of lemon
N Singh, NS Yarla, NJ Siddiqi, M de Lourdes Pereira, B SharmaMedicinal Chemistry 17 (3), 187-202, 2021202
13
2021
Natural drug cancer treatments, strategies from herbal medicine to chemical or biological drugs
DY Lu, TR Lu, NS Yarla, Y Lu, JY Che, J Ding, B Xu, H Zhu, Y Shen, ...Studies in Natural Products Chemistry 66, 91-5, 2020202
11
2020
Molecular docking and in vitro studies of soap nut trypsin inhibitor (SNTI) against phospholipase A2 isoforms in therapeutic intervention of inflammatory diseases
GVD Sirisha, KV Rachel, K Zaveri, NS Yarla, P Kiranmayi, M Ganash, ...International journal of biological macromolecules 114, 556-564, 20120
8
2018

Referred From: https://scholar.google.co.in/citations?user=0d3QHT8AAAAJ&hl=en

Cited by
Citations 2852
h-index 26
i10-index 68
Recommended Journals
Open Access Journals